Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder-Reference-Cited by-同舟云学术

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder

Published:2014-06-20 Issue:aop Volume: Page:1-27
ISSN:1935-1232
Container-title:Clinical Schizophrenia & Related Psychoses
language:en
Short-container-title:Clinical Schizophrenia & Related Psychoses

Author:

Hirasawa-Fujita Mika,Bly Michael J,Ellingrod Vicki L,Dalack Gregory W,Domino Edward F

Publisher

Longdom Group

Subject

Psychiatry and Mental health,General Medicine

Reference85 articles.

1. Smoking, nicotine and neuropsychiatric disorders

2. Smoking and mental illness: results from population surveys in Australia and the United States

3. Co-Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders

4. Smoking and mental illness

5. Smoking and Mental Illness

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of natural product regulation of opioid receptors in the treatment of human disease;Pharmacology & Therapeutics;2018-04

2. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort;European Archives of Psychiatry and Clinical Neuroscience;2018-02-02

3. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2017-10

4. A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology;Translational Psychiatry;2016-07

5. Endogenous opiates and behavior: 2014;Peptides;2016-01